Worth investing in pharmaceutical stocks
Worth investing in pharmaceutical stocks, which requires access to relevant information in order to answer the answer, according to years of learning experience, if the answer is worth investing in pharmaceutical stocks, can make you twice as much, the following share worth investing in pharmaceutical stocks related methodology experience, for your reference and reference.
Worth investing in pharmaceutical stocks
Investing in pharmaceutical stocks requires careful stock selection because this industry is characterized by high risk and high return. Here are some pharmaceutical stocks that may be worth investing in:
Hengrui Medicine (600276): the company is a large-scale integrated pharmaceutical company that specializes in the research and development of innovative and generic drugs. Hengrui has strong R&D capabilities and has several innovative drugs in clinical trials.
Shanghai Pharmaceutical (600607): The company is one of the leading companies in China's pharmaceutical industry, mainly engaged in the manufacture and sale of drugs. Shanghai Pharm has a rich product line and a wide range of sales channels and partners in the Chinese market.
Baiyunshan (600332): The company is a large integrated pharmaceutical company in China's pharmaceutical industry, mainly producing antibiotics, antiviral drugs, cardiovascular drugs and so on. Baiyunshan has also made some progress in drug research and development, and has extensive sales channels and partners in the Chinese market.
It should be noted that investing in pharmaceutical stocks requires an understanding of the relevant industry and market risks, as well as adequate due diligence and risk assessment. Meanwhile, pharmaceutical stocks are highly volatile, and investors should manage their risk well and control their positions and risks.
Pharmaceutical stocks worth getting
There are many pharmaceutical stocks, and here are a few to recommend:
1. cro, customized R&D and production, and other comprehensive and integrated pharmaceutical R&D services.
2. Tigermed: Tigermed is a leading clinical contract research organization in China, capable of providing cutting-edge globalized clinical research services for pharmaceutical products and medical solutions.
3. Kaleidoscope: Kaleidoscope is the world's leading provider of outsourced drug discovery and development services characterized by innovation. At present, the company has the advantage of distinctive internationalization features, and has invested in a number of parks in China to build a new super-large-scale industrial base for drug clinical trials.
4. Kanglong Huacheng: Kanglong Huacheng is a global leader in drug discovery and development services, providing new drug discovery and development of the whole process of services.
5. Zhaoyan New Drugs: Zhaoyan New Drugs provides non-clinical safety evaluation of drugs, preclinical research and development of new drugs, and is one of the earliest preclinical research service providers in China to set up a center for non-clinical safety evaluation of drugs.
The above recommendations are ranked in no particular order and are for reference only, so you can choose the right pharmaceutical stocks for yourself according to your needs and market changes.
High-end Pharma Stocks Worth Investing In
Investing in high-end pharma stocks requires attention to a company's R&D capabilities, product pipeline, sales capabilities, industry competitive landscape, industry trends, and other factors. Here are some high-end pharma stocks to watch:
__ WuXi PharmaTech (02359): The company is the largest outsourcing organization for drug clinical R&D services in China, providing integrated, full-process supply chain services for the global biopharmaceutical industry.
__Hengrui Medicine (600276): the company is a leading domestic chemical pharmaceutical company, dedicated to the research and development of innovative drugs and industrial transformation.
__Meridian (300760): the company is a leading provider of medical devices and solutions, with product lines covering a wide range of areas.
__Tiger Pharmaceuticals (300347): the company is a leading medical technology services and R&D outsourcing company in China, providing clinical trials and related services for the pharmaceutical industry.
__Kenfan Bio (300529): the company is a domestic leader in the field of blood purification, and its main products include hemoperfusion devices, hemodialyzers and other medical devices.
The investment value of these stocks depends on their performance, market prospects, industry competition dynamics and other factors, and investors need to consider them according to their own risk tolerance, investment objectives and time.
What are the foreign pharmaceutical stocks worth investing in
The following are some foreign pharmaceutical stocks that are worth paying attention to:
__Merck Serono, which will grow by 22 percent year-on-year in China in 2021, with products such as Baring Capsules and Dometic.
__Symmetrics, with 36% year-on-year growth in China in 2021, has more than 800 sales engineers and industry experts in its scientific division in China to respond quickly to customer needs.
__ Roche, with 17% year-on-year growth in China in 2021, which is Roche's largest global market.
__ Novartis, which will grow 14 percent year-on-year in China in 2021, is Novartis' second-largest global market after the U.S., according to its president of China, Colbert An.
__ Bayer, which will grow 14 percent year-on-year in China in 2021, is Bayer's second-largest market globally, said Pan Jinsheng, CEO of its Greater China region.
__ GlaxoSmithKline, with 14 percent year-on-year growth in China in 2021, said Zhou Tao, its president of China: China is GSK's highest-growth-rate market and one of the group's top three strategic markets globally.
These companies have stable growth and market share, and deserve long-term attention and investment. However, the investment market involves risks and investors need to make decisions based on their risk tolerance and investment objectives.
Chinese Pharmaceutical Stocks Worth Investing In
Investing in Chinese pharmaceutical stocks requires careful selection. Here are a few Chinese pharmaceutical stocks worth looking at:
1. Baiyunshan: Baiyunshan is a large pharmaceutical company in China whose products include antibiotics, anti-tumor drugs, digestive drugs and respiratory drugs. Baiyunshan has strong R&D strength and a rich product line, as well as expansion in overseas markets.
2. Myriad Medical: Myriad Medical is China's leading medical device manufacturer, with products covering life information and support, in vitro diagnostics, medical imaging and other fields. In recent years, Myriad Medical has been expanding its product line and market share through independent research and development and active acquisitions.
3. WuXi PharmaTech: WuXi PharmaTech is one of the largest drug discovery and development service providers in China, whose business includes drug discovery, drug development and clinical trials. WuXi PharmaTech provides comprehensive drug discovery and development services by partnering with leading global pharmaceutical companies.
4. Hualan Bio: Hualan Bio is one of the leading blood product companies in China, whose products include human albumin, immunoglobulin and clotting factors. Hualan Bio has strong R&D strength and market competitiveness, as well as expansion in overseas markets.
Please note that investment involves risks, so be sure to conduct sufficient research and analysis before investing.
That's it for the introduction of pharmaceutical stocks worth investing in.